News

A judge ruled that alleged harms to the state "flow from concerns about a decision that the Trump administration has not made and may never make."

The measure, released by HHS on Thursday, would roll back so-called safe-harbor protections for drug rebates.

Lawmakers are digging in on investigations into high drug prices, but the pharma industry does not look to be very cooperative.

Building a drug-price negotiating unit from scratch isn't trivial, and the company is doing it on a very tight timeline.

The rule no longer requires larger employers to electronically file detailed reports on workplace injuries and illnesses.

A new poll shows that citizens of developed countries no longer believe in 'rags-to-riches' stories.